← SynDRA
CRENIGACESTAT
SynDRA canonical compound SYN0037052 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | NOTCH1 | NOTCH2 | NOTCH3 | NOTCH4 |
| Mechanism of action | notch signaling inhibitor |
All known targets
- NOTCH1
- NOTCH4
- NOTCH2
- NOTCH3
Mechanisms of action (all sources)
- notch signaling inhibitor
- NOTCH4 INHIBITOR
- NOTCH1 INHIBITOR
Cross-references
Synonyms
- JSMD-194
- JSMD194
- LY-3039478
- LY3039478
- UNII-923X28214S
- 4,4,4-Trifluoro-N-((S)-1-(((S)-5-(2-hydroxyethyl)-6-oxo-6,7-dihydro-5H-benzo[d]pyrido[2,3-b]azepin-7-yl)amino)-1-oxopropan-2-yl)butanamide
- 923X28214S
- butanamide, n-[(1s)-2-[[(7s)-6,7-dihydro-5-(2-hydroxyethyl)-6-oxo-5h-pyrido[3,2-a][3]benzazepin-7-yl]amino]-1-methyl-2-oxoethyl]-4,4,4-trifluoro-
- Butanamide, N-((1S)-2-(((7S)-6,7-dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido(3,2-a)(3)benzazepin-7-yl)amino)-1-methyl-2-oxoethyl)-4,4,4-trifluoro-
- LY 3039478
- crenigacestatum
- RefChem:919179
- BMS-986405
- Gamma-Secretase Inhibitor LY3039478
- Crenigacestat [USAN]
- MFCD26142650
- CRENIGACESTAT [INN]
- Crenigacestat (USAN/INN)
- CRENIGACESTAT [WHO-DD]
- orb1303976
- Crenigacestat (LY3039478)
- SCHEMBL14657256
- SCHEMBL29384049
- SCHEMBL29684828
- GTPL11359
- C22H23F3N4O4
- CHEBI:232469
- YCBAQKQAINQRFW-UGSOOPFHSA-N
- YCBAQKQAINQRFW-UGSOOPFHSA-O
- HMS3886L11
- EX-A1983
- NSC787253
- AKOS025291098
- CCG-269391
- CS-5807
- FT76166
- NSC-787253
- AC-32768
- HY-12449
Look up CRENIGACESTAT in the interactive SynDRA portal →